Kliniki Adhd Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services

Secondary Activities: Pharmacies and Drug Stores | Book Stores | Electronic Shopping and Mail-Order Houses | Administrative Management and General Management Consulting Services | All Other Miscellaneous Schools and Instruction | Outpatient Care Centers | All Other Miscellaneous Ambulatory Health Care Services | General Medical and Surgical Hospitals

Full name: Kliniki Adhd Sp. z o.o.

Profile Updated: June 14, 2025

Kliniki Adhd Sp. z o.o. is based in Poland, with the head office in Warsaw. The company operates in the Ambulatory Health Care Services industry. The company was established on August 24, 2022. In 2025, the company reported a net sales revenue increase of 16.14%. A growth of 29.34% was recorded in its total assets. The net profit margin of Kliniki Adhd Sp. z o.o. decreased by 0.76% in 2025.

Headquarters
Ul. Karola Bohdanowicza 17/37
Warsaw; Mazowieckie; Postal Code: 02-127

Contact Details: Purchase the Kliniki Adhd Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Kliniki Adhd Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Kliniki Adhd Sp. z o.o. report to view the information.

Incorporation Date:

August 24, 2022

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

27.87%

Purchase this report to view the information.

27.87%

Purchase this report to view the information.

27.87%

Company Performance

Financial values in the chart are available after Kliniki Adhd Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

16.14%▲

Total Operating Revenue

16.14%▲

Operating Profit

N/A

EBITDA

224.94%▲

Net Profit/Loss for the Period

-89.89%▼

Total Assets

29.34%▲

Total Equity

-10.29%▼

Operating Profit Margin

N/A

Net Profit Margin

-0.76%▼

Return on Equity (ROE)

3.91%▲

Quick Ratio

-0.35%▼

Cash Ratio

0.08%▲

Similar companies

Related EMIS Industry Reports